Genmab | GEN - ДОЛГ

Биржевая цена
1,690.00
Изменение за день
35.00 2.11%
Ежемесячно
-1.34%
Ежегодный
20.80%
Q2 прогноз
1,628.53




ДОЛГ Изменить Дата
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Almirall EUR 342.86M 61.94M 2025-12
Amarin USD 0 0 2025-03
Amgen USD 54.6B 17M 2025-12
argenx SE USD 43.15M 4.1M 2025-06
AstraZeneca USD 33.92B 4.3B 2026-03
Bayer EUR 39.39B 1.31B 2025-03
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Demant DKK 20.99B 4.81B 2025-12
Exelixis USD 176.46M 3.38M 2025-09
Fresenius Medical Care EUR 10.8B 322.94M 2025-12
Galapagos EUR 7.5M 3.36M 2025-09
Genmab DKK 148M 5M 2025-06
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
GN Store Nord DKK 11.79B 15M 2025-06
GRIFOLS EUR 9.57B 746.56M 2025-12
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Insmed USD 727.89M 163.33M 2025-12
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.1B 2.7B 2025-09
Novartis USD 35.38B 2.74B 2025-12
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
UCB EUR 3.03B 12M 2024-12